Correction: Corrigendum: The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors

被引：0
|
作者：
Alex Berndt
Simon Miller
Olusegun Williams
Daniel D Le
Benjamin T Houseman
Joseph I Pacold
Fabrice Gorrec
Wai-Ching Hon
Pingda Ren
Yi Liu
Christian Rommel
Pascale Gaillard
Thomas Rückle
Matthias K Schwarz
Kevan M Shokat
Jeffrey P Shaw
Roger L Williams
机构：
来源：
Nature Chemical Biology | 2010年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nat. Chem. Biol. 6, 117–124 (2010); published online 10 January 2010; corrected after print 12 February 2010 and 2 March 2010 In the version of this article initially published, the structure of p110δ in complex with the inhibitor IC87114 was refined with an incorrect inhibitor structure (original Protein Data Bank accession code 2WXE).
引用
下载
收藏
页码：306 / 306
相关论文
共 50 条
  • [21] Enhanced PI3K p110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a p110α-Selective PI3K Inhibitor
    Brady, Samuel W.
    Zhang, Jian
    Seok, Daniel
    Wang, Hai
    Yu, Dihua
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (01) : 60 - 70
  • [22] Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110α inhibitors
    Kendall, Jackie D.
    Rewcastle, Gordon W.
    Frederick, Raphael
    Mawson, Claire
    Denny, William A.
    Marshall, Elaine S.
    Baguley, Bruce C.
    Chaussade, Claire
    Jackson, Shaun P.
    Shepherd, Peter R.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) : 7677 - 7687
  • [23] Human tumor mutants in the p110α subunit of PI3K
    Liu, Zhenning
    Roberts, Thomas M.
    CELL CYCLE, 2006, 5 (07) : 675 - 677
  • [24] p110 δ PI3K as a therapeutic target of solid tumours
    Xenou, Lydia
    Papakonstanti, Evangelia A.
    CLINICAL SCIENCE, 2020, 134 (12) : 1377 - 1397
  • [25] Discovery of benzoxazepin PI3K inhibitors and optimization of p110-alpha selectivity
    Ndubaku, Chudi O.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [26] The catalytic PI3K isoforms p110γ and p110δ contribute to B cell development and maintenance, transformation, and proliferation
    Beer-Hammer, Sandra
    Zebedin, Eva
    von Holleben, Max
    Alferink, Judith
    Reis, Bernhard
    Dresing, Philipp
    Degrandi, Daniel
    Scheu, Stefanie
    Hirsch, Emilio
    Sexl, Veronika
    Pfeffer, Klaus
    Nuernberg, Bernd
    Piekorz, Roland P.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 87 (06) : 1083 - 1095
  • [27] Non-redundant involvement of the PI3K isoforms p110γ and p110δ in the development and survival of myeloid cells
    Bucher, Kirsten
    Schmitt, Fee
    Autenrieth, Stella
    Nuernberg, Bernd
    Beer-Hammer, Sandra
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S32 - S32
  • [28] The PI3Ks p110α and p110δ control regulatory T cell function
    Slack, E. C. M.
    Soond, D. R.
    Scudamore, C. L.
    Garden, O. A.
    Okkenhaug, K.
    IMMUNOLOGY, 2011, 135 : 54 - 54
  • [29] Dominant Role of the p110β Isoform of PI3K over p110α in Energy Homeostasis Regulation by POMC and AgRP Neurons
    Al-Qassab, Hind
    Smith, Mark A.
    Irvine, Elaine E.
    Guillermet-Guibert, Julie
    Claret, Marc
    Choudhury, Agharul I.
    Selman, Colin
    Piipari, Kaisa
    Clements, Melanie
    Lingard, Steven
    Chandarana, Keval
    Bell, Jimmy D.
    Barsh, Gregory S.
    Smith, Andrew J. H.
    Batterham, Rachel L.
    Ashford, Michael L. J.
    Vanhaesebroeck, Bart
    Withers, Dominic J.
    CELL METABOLISM, 2009, 10 (05) : 343 - 354
  • [30] PI 3-kinase p110β:: a new target for antithrombotic therapy
    Jackson, SP
    Schoenwaelder, SM
    Goncalves, I
    Nesbitt, WS
    Yap, CL
    Wright, CE
    Kenche, V
    Anderson, KE
    Dopheide, SM
    Yuan, YP
    Sturgeon, SA
    Prabaharan, H
    Thompson, PE
    Smith, GD
    Shepherd, PR
    Daniele, N
    Kulkarni, S
    Abbott, B
    Saylik, D
    Jones, C
    Lu, L
    Giuliano, S
    Hughan, SC
    Angus, JA
    Robertson, AD
    Salem, HH
    NATURE MEDICINE, 2005, 11 (05) : 507 - 514
12345